昌吉割包茎手术有危险吗昌吉到那看妇科病好,昌吉包皮手术在什么季节做好,佳美妇科好吗,昌吉包皮割过短怎么办,昌吉阳痿治疗费用贵吗,昌吉怎么让男人有持久力,昌吉哪家可以做无痛人流

The Georgia Democratic Party and gubernatorial candidate Stacey Abrams' campaign filed a lawsuit in federal court Sunday asking for rejected absentee ballots and provisional ballots to be counted in the Georgia governor's race.The lawsuit challenges the rejection of more than 1,000 absentee ballots for missing information or mismatching information, like birth dates or addresses.The lawsuit also seeks relief for voters whose provisional ballots were rejected in Gwinnett and Dekalb counties, which are in the Atlanta metro area, because they are registered in a different county.CNN has not projected a winner in the race.Republican candidate Brian Kemp currently leads Abrams with 50.3% of the vote. If Kemp's share dips below 50%, the race automatically goes into a run-off on December 4, even if Kemp is the top vote-getter. For now, Kemp's lead stands at nearly 59,000 votes. 891

The decision to reintroduce gray wolves in Colorado will be decided by the people, and both sides of the issue say the decision will impact the entire country.“Only in 2020, the weird year that we are having would Colorado be voting to introduce a species that’s already here in Colorado,” said Shawn Martini, the vice president of advocacy for the Colorado Farm Bureau.“The western part of Colorado is primarily owned, and majority-owned, by the people as public lands,” said Rob Edward, who is part of the Rocky Mountain Wolf Project. “We all have interests on what happens on our public lands.”For centuries, the gray wolf roamed North America in large populations. But in the 1900s, the wolves were nearly hunted out of existence.The wild wolves haven’t lived in Colorado since 1940, and the U.S. Fish and Wildlife Service classified the animal as an endangered species in 1978.“They are the missing link in the Rocky Mountain chain,” Edward said. “From the high arctic to New Mexico, we can re-establish a population of wolves again by reintroducing wolves to western Colorado. The presence of wolves on those wild landscapes is important for the long-term health of those landscapes.”With Proposition 114 in Colorado, the people will be able to vote in November on whether this will become a reality. This is something that has never happened in the nation’s history.“Wolves are already all over the place,” Martini said. “They’ve come down from Wyoming and Montana through a natural process. We’re asking voters to say no to this ballot initiative, because it makes something a natural process into a political one.”Having people vote on this is something Martini is strongly against.“So, this the first time a species would be introduced into a state via a ballot measure,” Martini said. “The reason it’s never been done before because it’s a really bad idea to make a scientific process a political one. The Colorado Parks and Wildlife and biologists should be the ones making this decision, not voters who don’t always have access to the info and are not biologists and who don’t do this for a living.”The main reason wolf advocates like Edwards want to re-introduce wolves to the area is that they believe it could improve the ecosystem. In 1995, the gray wolf was reintroduced into the greater Yellowstone ecosystem to help manage the high population of elk. But that decision wasn’t voted on by the people.Biologists came up with a plan and brought it to Congress. After years of public comment, the secretary of the interior finally signed off on the project.“Colorado is not Yellowstone,” Martini said. “Yellowstone is subject to a ton of environmental regulations, so the people managing the area don’t have the same tools as Colorado does.”Regardless of what side people are on this issue, both sides agree that this a historic ballot measure that could change the course of the country ecologically and politically. 2941

The COVID-19 death of the speaker of the New Hampshire House of Representatives has raised fears that other members of one of the world's largest legislatures might have been exposed at their swearing-in ceremony last week. A medical examiner announced the cause of death Thursday of 71-year-old Dick Hinch. Hinch was found dead in his home.He was photographed at the outdoor swearing-in wearing a mask improperly, without it covering both his nose and mouth. Dozens reportedly attended without wearing masks at all. Several Republican lawmakers have tested positive after attending an indoor meeting in late November where many attendees didn't wear masks. One Republican representative says Hinch's death may be a result of “peer pressure exerted by those in the Republican Party who refuse to take reasonable precautions."At a news conference Thursday, New Hampshire Governor Chris Sununu, a fellow Republican, called Hinch a "tireless leader" and close friend. He then said Hinch's death was a "cautionary tale" about not wearing a mask properly.“For those who are just out there doing the opposite just to make some ridiculous political point, it is horribly wrong,” Sununu said. “Please use your heads. Don’t act like a bunch of children, frankly.”Other state Republicans were harsher in their messaging. Representative William Marsh, a retired doctor, posted on Twitter, “Those in our caucus who refused to take precautions are responsible for Dick Hinch’s death." 1479

The Centers for Disease Control and Prevention is now publicly acknowledging people can be infected with the coronavirus through airborne transmission, especially in enclosed spaces with inadequate ventilation.The update embraces growing evidence and international research showing the coronavirus can linger in the air longer - for minutes and hours - and travel farther than six feet.The update comes two weeks after the official CDC website was updated to reflect this, only to be removed a few days later with the agency saying it was “posted in error” before it was fully reviewed.The draft language seemed to imply aerosol or airborne transmission was the main way the coronavirus spreads, and the CDC says that is not the case.“Infections occur mainly through exposure to respiratory droplets when a person is in close contact with someone who has COVID-19,” the CDC states.Their added section is titled “COVID-19 can sometimes be spread by airborne transmission,” and includes information about smaller particles lingering in the air after an infected person had left the space. "Some infections can be spread by exposure to virus in small droplets and particles that can linger in the air for minutes to hours," it reads.“There is evidence that under certain conditions, people with COVID-19 seem to have infected others who were more than 6 feet away. These transmissions occurred within enclosed spaces that had inadequate ventilation. Sometimes the infected person was breathing heavily, for example while singing or exercising,” the new section on the CDC’s website reads. “These transmissions occurred within enclosed spaces that had inadequate ventilation.”The World Health Organization changed their guidance in July and noted the prevalence of airborne transmission of coronavirus and particles lingering in the air. Hundreds of scientists encouraged the WHO to make the acknowledgement following research and studies. 1943

The Food and Drug Administration resisted pressure from the Trump administration on Tuesday by releasing a set of guidelines that could push an emergency use authorization of a coronavirus vaccine past Election Day.The FDA’s new guidance notes that an Oct. 22 meeting of its Vaccines and Related Biological Products Advisory Committee will not be to discuss specific vaccine candidates. The FDA noted that a vaccine candidate must be at least 50% effective. Vaccine candidates should include a median follow-up duration of at least two months after completion of the full vaccination regimen to help provide adequate information to assess a vaccine’s risk-benefit."Being open and clear about the circumstances under which the issuance of an emergency use authorization for a COVID-19 vaccine would be appropriate is critical to building public confidence and ensuring the use of COVID-19 vaccines once available,” Peter Marks, M.D., Ph.D., director of the FDA's Center for Biologics Evaluation and Research, said. The FDA's new guidance on emergency use authorization of COVID-19 vaccines underscores that commitment by further outlining the process and recommended scientific data and information that would support an emergency use authorization decision.“In addition to outlining our expectations for vaccine sponsors, we also hope the agency's guidance on COVID-19 vaccines helps the public understand our science-based decision-making process that assures vaccine quality, safety and efficacy for any vaccine that is authorized or approved."Trump previously said he would consider overruling the FDA on its vaccine guidelines in hopes of speeding up the process. There is both health and economic pressure for a vaccine to be developed as the coronavirus continues to claim an average of 800 US lives a day, according to Johns Hopkins University data. The number of deaths per day related to the coronavirus is expected to increase as the weather gets colder, according to the University of Washington’s Institute for Health Metrics and Evaluation.On Tuesday, House Speaker Nancy Pelosi blasted the Trump administration for involving itself in the vaccine approval process.“Trust in the vaccine is key to the acceptance of the American people, which is essential to crushing the virus.“The White House’s decision to reject FDA medical experts’ minimum safety and efficacy standards for emergency use authorization of a vaccine is an extremely dangerous act. We are all praying for a safe and effective vaccine as soon as possible, but the damage of the Trump Administration rushing a vaccine before it is known to be safe and effective could be catastrophic."Dr. Anthony Fauci told CNN's Chris Cuomo on Monday that he expects a vaccine candidate to be given an emergency use authorization by the end of 2020. "By the time we get to November, December, maybe earlier, I don't think it's going to be earlier, but it's still possible," Fauci said. "It will be early, but I think comfortably around November or December we'll know whether or not the vaccine is safe and effective. I actually am cautiously optimistic from what I've seen about preliminary data in phase one, that there's a very good chance we'll have a safe and effective vaccine." 3256